ArticleFrontiers in aging neuroscience2026
Amygdala subregion MRI alterations in Parkinson's disease correlate with olfactory function.
Article in Frontiers in aging neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Olfactory dysfunction affects 80-90% of Parkinson's disease (PD) patients. The amygdala, a key olfactory node, comprises functionally distinct subregions. We investigated volumetric changes in nine amygdala subregions across PD stages and their relationship with olfactory function. Methods: In this cross-sectional study, 65 PD patients (40 early stage, Hoehn-Yahr 1.0-2.5; 25 late- stage, 3.0-5.0) and 45 healthy controls underwent high-resolution 3D-T1WI MRI. Automated segmentation quantified bilateral volumes of nine amygdala subregions. Olfactory function was assessed using Sniffin' Sticks (threshold, discrimination, identification, TDI score). Cognitive function was evaluated by MMSE. Statistical analyses included ANCOVA/GLM with Bonferroni correction and Spearman partial correlation. Results: PD patients exhibited significant volume reductions in bilateral cortical nucleus (Co), accessory basal nucleus (AB), cortico-amygdaloid transition area (CAT), and right anterior amygdaloid area (AAA) versus controls ( Conclusion: PD involves subregion-selective amygdala atrophy, with Co and AAA affected early, followed by AB and CAT, exhibiting a right-lateralized pattern. The weak correlation between right AAA volume and olfactory function suggests a specific role in PD-related olfactory dysfunction, providing novel insights into its structural basis. Additionally, left Me volume correlated with MMSE independent of stage, implying a structural biomarker for cognition.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.